|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.70 USD | -0.13% |
|
+0.25% | +26.23% |
| 07-16 | Ingevity Receives BASt Approval For Evotherm P35 Warm-Mix Additive In Germany | CI |
| 06-25 | Ingevity Names Ryan Cotterman as Chief Accounting Officer | MT |
Company Valuation: Ingevity Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,817 | 2,632 | 1,711 | 1,481 | 2,128 | 2,597 | - | - |
| Change | - | -6.55% | -35.01% | -13.42% | 43.69% | 22.04% | - | - |
| Enterprise Value (EV) 1 | 3,791 | 4,028 | 3,082 | 2,814 | 3,259 | 3,637 | 3,534 | 3,480 |
| Change | - | 6.25% | -23.49% | -8.69% | 15.8% | 11.62% | -2.83% | -1.53% |
| P/E | 24.3x | 12.8x | -315x | -3.44x | -12.8x | 19.3x | 13x | 11.7x |
| PBR | 4.18x | 3.76x | - | 7.58x | 70.7x | - | - | - |
| PEG | - | 0.1x | 3x | -0x | 0.2x | -0x | 0.3x | 1.1x |
| Capitalization / Revenue | 2.02x | 1.58x | 1.01x | 1.05x | 1.65x | 2.34x | 2.3x | 2.25x |
| EV / Revenue | 2.72x | 2.41x | 1.82x | 2x | 2.53x | 3.28x | 3.13x | 3.01x |
| EV / EBITDA | 8.98x | 8.9x | 7.77x | 7.76x | 8.2x | 9.52x | 8.5x | 8.16x |
| EV / EBIT | 12.1x | 11.7x | 40.1x | 11.1x | 11.2x | 12.7x | 11.2x | 10.5x |
| EV / FCF | 20x | 23.6x | 32.3x | 55.2x | 11.9x | 13.2x | 14.5x | 13.5x |
| FCF Yield | 4.99% | 4.24% | 3.09% | 1.81% | 8.39% | 7.56% | 6.9% | 7.43% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.95 | 5.5 | -0.15 | -11.85 | -4.61 | 3.875 | 5.76 | 6.4 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,392 | 1,668 | 1,692 | 1,406 | 1,289 | 1,109 | 1,131 | 1,154 |
| EBITDA 1 | 422.2 | 452.6 | 396.8 | 362.7 | 397.5 | 382 | 415.8 | 426.6 |
| EBIT 1 | 312.3 | 343.8 | 76.9 | 254.4 | 291.1 | 287.5 | 316 | 330 |
| Net income 1 | 118.1 | 211.6 | -5.4 | -430.3 | -167.1 | 135.4 | 192.4 | 211 |
| Net Debt 1 | 974.6 | 1,396 | 1,371 | 1,333 | 1,130 | 1,040 | 937 | 883 |
| Reference price 2 | 71.70 | 70.44 | 47.22 | 40.75 | 59.18 | 74.70 | 74.70 | 74.70 |
| Nbr of stocks (in thousands) | 39,286 | 37,372 | 36,231 | 36,349 | 35,964 | 34,772 | - | - |
| Announcement Date | 23/02/22 | 27/02/23 | 21/02/24 | 18/02/25 | 25/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 19.3x | 3.28x | 9.53x | - | 2.6B | |
| 23.29x | 4.26x | 11.77x | 1.67% | 82.21B | |
| 10.05x | 0.9x | 7.67x | 4.74% | 47.4B | |
| 60.48x | 9.31x | 41.48x | 0.94% | 16.82B | |
| 15.38x | 0.98x | 7.2x | 2.42% | 15.38B | |
| 14.15x | 0.77x | 5.34x | 2.68% | 9.95B | |
| 16.33x | 0.7x | 7.94x | 3.16% | 9.58B | |
| 39.31x | 5.1x | 22.36x | 0.31% | 9.05B | |
| 29.76x | 1.53x | 8.2x | 2.34% | 8.06B | |
| 5.38x | 0.7x | 3.28x | -.--% | 7.39B | |
| Average | 23.34x | 2.75x | 12.48x | 2.03% | 20.84B | |
| Weighted average by Cap. | 22.20x | 3.12x | 12.41x | 2.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NGVT Stock
- Valuation Ingevity Corporation
Select your edition
All financial news and data tailored to specific country editions
